These drugs are helping some people
95% CI 0.60, 0.79) users,59 and also in AD in a separate study for exenatide which used claims data from a 20% random sample of Medicare beneficiaries with T2DM.60 Two further studies using TriNetX electronic health records (EHRs) but without an active comparator group found a beneficial association between GLP-1RAs and dementia risk in people with T2DM and obesity.61 62 On this same dataset, SGLT-2i was found to be slightly superior to GLP-1RAs for dementia risk (HR 0.92
Another cause is a diet that is low in L-Carnitine-rich foods, such as red meat and dairy products
Correcting these can modestly improve symptoms, particularly inattention and hyperactivity
The 10 mg/mL concentration target is the same for both, but you are obviously using different water volumes (0.5 mL for 5 mg semaglutide, 1 mL for 10 mg semaglutide, 3 mL for 30 mg tirzepatide)
Find My Program Medication may support appetite